Symbol
TRVI on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership
15.1M shares
Security Ownership
12%

New Enterprise Associates 16, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)

2025-08-11 - New Enterprise Associates 16, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.1M shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI). This represents 12% percent ownership of the company.